N-Terminal Truncated Cardiac TnI Improves Cardiac Function In Vivo and Rescues Restrictive Cardiomyopathy  by Jean-Charles, Pierre-Yves et al.
452a Tuesday, March 8, 20112451-Pos Board B437
N-Terminal Truncated Cardiac TnI Extends Frank-Starling Response of
the Heart
Hanzhong Feng, Xupei Huang, J.-P. Jin.
Cardiac TnI (cTnI) has an N-terminal extension containing two protein kinase
A (PKA) phosphorylation sites, Ser23/24, and its removal by restrictive prote-
olysis in cardiac adaptation improves myocardial relaxation. Through trans-
genic expression of the N-terminal truncated cTnI (cTnI-ND) in the heart of
endogenous cTnI knockout mice, we studied the function of cardiac muscle
containing only cTnI-ND. The pure cTnI-ND hearts showed no hypertrophy
or dilation with normal baseline function as compared to wild type controls
(WT), confirming the non-destructive nature of cTnI-ND. Echocardiography
found increased left ventricular end diastolic dimension in cTnI-ND hearts as
compared to WT, implying increased relaxation and compliance in vivo. A se-
ries of preloads was tested in ex vivo working hearts for the effects of cTnI-ND
on Frank-Starling response. cTnI-ND hearts showed responses to 5-10 mmHg
preloads similar to that of WT. When preload was increased from 10 to 20
mmHg, cTnI-ND hearts exhibited better maintained left ventricular relaxation
velocity, lower left ventricular end diastolic pressure and larger stroke volume
responses than that of WT hearts. 10 nM isoproterenol further increased the
positive effects of cTnI-ND on the responses of cardiac function to preloads,
indicating that cTnI-ND enhances Frank-Starling relationship in the absence
of direct effect of PKA phosphorylation at Ser23/24. Slack sarcomere length
in isolated cardiomyocytes and the optimal sarcomere length for maximum ten-
sion development in intact left ventricular papillary muscle from cTnI-NDmice
were similar to that of WT, suggesting that cTnI-ND extends the range of
Frank-Starling response to high preloads by enhancing contractility indepen-
dent of further increases in sarcomere length. The results demonstrated that
the removal of cTnI N-terminal extension by restrictive proteolysis provides
a novel posttranslational modification to utilize Frank-Starling mechanism in
cardiac adaptation to physiological and pathological stresses.
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Myopathic Splice-Out of the Exon 7 segment of Cardiac Troponin T
Predominantly Impairs Systolic Function of the Heart
Hanzhong Feng, Guozhen Chen, Changlong Nan, J.-P. Jin.
The abnormal splice-out of the exon 7-encoded segment in the N-terminal vari-
able region of cardiac troponin T (cTnT-DE7) found in turkeys and dogswith di-
lated cardiomyopathy significantly reduced the function of transgenic mouse
hearts over-expressing cTnT-DE7 (Wei et al., JBC, 2010). Significantly de-
creased left ventricular peak pressure and contractile and relaxation velocities
with elongated isovolumic contraction and relaxation time were seen in ex
vivo working hearts from cTnT-DE7 mice in the absence of beta-adrenergic
tone, which were correctable by physiological levels of isoproterenol. To further
investigate the pathogenic mechanism of cTnT-DE7 under systemic neurohu-
moral regulation, echocardiography was employed to measure the function of
cTnT-DE7 transgenic mouse hearts in vivo. No atrial enlargement, ventricular
hypertrophy or dilation was detected in the hearts of 3 months old cTnT-DE7
mice, indicating a compensated state. However, left ventricular fractional short-
ening and ejection fractionwere significantly decreased in cTnT-DE7mice com-
pared to wild type controls. Under both baseline and beta-adrenergic stimulated
conditions, the left ventricular outflow tract velocity and gradient were both sig-
nificantly decreased in the transgenicmouse hearts, indicating decreased systolic
function. The impaired systolic heart function in vivo without changes in dia-
stolic function suggests that cTnT-DE7 primarily reduces contractile function
of the cardiacmuscle. Interestingly, a restrictive proteolytic deletion of theN-ter-
minal variable region of cTnT (Feng et al., J. Physiol. 2008) was increased in the
cTnT-DE7 hearts in vivo. This adaptive response may compensate for the de-
creased systolic function from the N-terminal abnormality of cTnT-DE7. Our
study demonstrated that the N-terminal variable region of cTnT is a regulatory
element for cardiac systolic function and a therapeutic target in heart failure.
2453-Pos Board B439
Pathophysiologic Changes Induced by Mutations in the TNT1 Domain of
cTnT that Cause FHC
Lauren Tal, Rachel K. Moore, Candice Dowell-Martino, Jil C. Tardiff.
Familial Hypertrophic Cardiomyopathy (FHC) is a primary cardiac muscle dis-
order and one of the most common causes of sudden cardiac death in young peo-
ple. Amajority of Cardiac Troponin T (cTnT)mutations are located in the TNT1
domain and cluster at its N- and C-termini. We are investigating the cTnT dele-
tion of glutamine 160 (delta-160E) that is known to be a severe mutation located
in a predicted hinge region at the C-terminal end of TNT1. Previous in vitromo-
tility studies in our laboratory showed that mutations in this region disrupt weak
electrostatic interactions between the thin filament and myosin necessary for
strong crossbridge formation. In the current study, we aim to examine the down-stream pathophysioloic consequences of this mutation. Cardiac myocytes iso-
lated from hearts of transgenic mice expressing delta-160E cTnT with 35%
and 70% replacement and non-transgenic siblings were used to study mechani-
cal function and calcium transients. Our study shows impairments in myocellu-
lar mechanics during contraction and relaxation and in the rise and decline of the
calcium transient. Furthermore, the alterations in calcium kinetics were dose-
dependent. These results support the progressive nature of delta-160E FHC sug-
gested by electron micrographs that demonstrate ultrastructural sarcomeric dis-
array that increase with transgene expression. In addition, we determined
downstream effects of the mutation on expression and function of calcium han-
dling proteins in transgenic mouse hearts using functional assays and immuno-
blotting. We found that the delta-160E cTnT mutation causes secondary
alterations in calcium handling, leading to decreased SR calcium uptake, in-
creased NCX expression, and increased diastolic leak through RyR2. Collec-
tively, these novel findings indicate a phenotype that is distinct from other
cTnT mutations and support the need to establish genotype-phenotype links in
order to better design molecular therapies to treat FHC.
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N-Terminal Truncated Cardiac TnI Improves Cardiac Function In Vivo
and Rescues Restrictive Cardiomyopathy
Pierre-Yves Jean-Charles, Yuejin Li, Changlong Nan, Guozheng Chen,
Han-Zhong Feng, J-P Jin, Xupei Huang.
Our previous studies have demonstrated that the phenotype of the transgenic
mouse hearts expressing a restrictive cardiomyopathy (RCM) cardiac troponin
I (cTnI) C-terminalmutation (R193H) is characterized by a diastolic dysfunction
and sudden cardiac death (SCD) (Du et al, 2006, 2008). We have also observed
that restrictive cleavage of the N-terminal extension of cTnI (cTnI-ND) that oc-
curs in physiological and pathological adaptations (Yu et al., 2001; Feng et al,
2008;McConnell et al., 2009) desensitizesmyofibril sensitivity for Ca2þ and en-
hances diastolic function in transgenicmice expressing cTnI-ND (Li et al, 2010).
In the present study, we generated double transgenicmice (Double-TG) express-
ing different levels of mutant cTnI R193H and cTnI-ND to investigate the dose-
dependent rescue effect of cTnI-ND and the mechanisms underlying the protec-
tive role of cTnI-ND in young and aged RCMmice. In 2-month-old Double-TG
mice, cTnI-ND rescuesRCMmice by correcting diastolic dysfunction caused by
cTnI R193H mutation in the heart. The rescue effect of cTnI-ND shows a dose-
dependent manner. In 8-10-month-old Double-TG mice, echocardiography and
Doppler data indicate that cTnI-ND rescues RCMmice not only by reversing the
diastolic dysfunction, but also by improving systolic function in the heart, since
both diastolic and systolic functions are deteriorated in aged RCM mice. Cell-
based assays measuring cardiac cell contractility further confirm the dose-
dependent protective effect of cTnI-ND in correcting the impaired relaxation
in isolated cardiac myocytes from various Double-TG mouse lines. Consistent
with the beneficial effect of cTnI-ND on the function of non-myopathic aging
hearts (Biesiadescki et al., 2010), these data demonstrate that cTnI-ND can res-
cue RCMphenotype not only by correcting diastolic dysfunction in youngRCM
mice but also by improving systolic function in aged RCM mice.
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Dose-Dependent Arrhythmia and Cardiac Dysfunction in Restrictive
Cardiomyopathy Mice Due to Troponin Mutations
Yuejin Li, Pierre-Yves Jean-Charles, Changlong Nan, Guozhen Chen,
Xupei Huang.
Restrictive cardiomyopathy (RCM) is associated with a cardiac troponin I
(cTnI) C-terminal mutation (R192H) in human patients. The transgenic mice
expressing this mutation have confirmed a phenotype of a diastolic dysfunction
and sudden cardiac death (SCD) (Du et al, 2006, 2008). In the present study, we
generated transgenic mice (cTnI193His) expressing different levels of mutant
cTnI R193H (mouse cTnI sequence) to investigate the dose-dependent cardiac
dysfunction and to reveal the cause of the death in RCM mice. Our results in-
dicated that the mice (cTnI193His/KO expressing only the mutant cTnI R193H at
a wild type cTnI-null background had a dramatic early death at one-month old
after birth. Telemetric ECG recording from these mice showed a significant
bradycardia starting on day 22 or 23 after birth and a significant ischemia
and arrhythmia 1-2 days before death. The diastolic function was deteriorated
in these mice determined by echocardiography compared to wild type and the
transgenic cTnI193His mice expressing 25% cTnI R193H and 75% wild type
cTnI. Cell-based experiments indicated that myocardial contractility decreased
significantly corresponding to the content of the mutant cTnI levels in cardiac
myocytes and the alteration of Ca2þ dynamics in the mutant cTnI cardiac my-
ocytes also showed a dose-dependent manner. Our study has demonstrated that
cTnI R193Hmutation-caused cardiac dysfunction is dose dependent. Bradycar-
dia is likely an adaptive mechanism of RCM mice to compensate for the pro-
longed relaxation. The main cause of the death in RCM mice is associated with
